Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Fryklund

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 21, 2004
Pharmacokinetics and metabolism of tesaglitazar, a novel dual-acting peroxisome proliferator-activated receptor alpha/gamma agonist, after a single oral and intravenous dose in humansH Ericsson, B Hamrén, S Bergstrand, et al.
European Journal of Biochemistry|January 2, 1978
Purified human somatomedin A and rat multiplication stimulating activity. Mitogens for cultured fibroblasts that cross-react with the same growth peptide receptorsM M Rechler, L Fryklund, S Nissley, et al.
Endocrine|December 15, 2010
Effects of constant infusion with insulin-like growth factor-I (IGF-I) to immature female rats on body weight gain, tissue growth, and sexual function : Evidence that such treatment does not affect sexual maturation or fertilityN M Gruaz, V d'Allèves, Y Charnay, et al.
Endocrine|February 1, 1997
Effects of constant infusion with insulin-like growth factor-I (IGF-I) to immature female rats on body weight gain, tissue growth and sexual function. Evidence that such treatment does not affect sexual maturation of fertilityN M Gruaz, V d'Allèves, Y Charnay, et al.
The Journal of Biological Chemistry|July 5, 1989
Isolation and characterization of a glycosylated form of human insulin-like growth factor I produced in Saccharomyces cerevisiaeP Gellerfors, K Axelsson, A Helander, et al.
Clinical Endocrinology|June 1, 1977
Increasing growth with raised circulating somatomedin but normal immunoassayable growth hormoneR Hoffenberg, A Howell, S Epstein, et al.
Clinical Endocrinology|August 31, 2002
The metabolic effects of short-term administration of physiological versus high doses of GH therapy in GH deficient adultsK Yuen, D Cook, K Ong, et al.
Acta Physiologica Scandinavica|February 1, 1986
Localization of IGF-I in adult rats. Immunohistochemical studiesI Andersson, H Billig, L Fryklund, et al.
Biochimica Et Biophysica Acta|September 11, 1987
Biological characterization of purified native 20-kDa human growth hormoneJ L Kostyo, A Skottner, P Brostedt, et al.
The Journal of Clinical Endocrinology and Metabolism|June 29, 2006
The d3/fl-growth hormone (GH) receptor polymorphism does not influence the effect of GH treatment (66 microg/kg per day) or the spontaneous growth in short non-GH-deficient small-for-gestational-age children: results from a two-year controlled prospective study in 170 Spanish patientsA Carrascosa, C Esteban, R Espadero, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 21, 2004
Pharmacokinetics and metabolism of tesaglitazar, a novel dual-acting peroxisome proliferator-activated receptor alpha/gamma agonist, after a single oral and intravenous dose in humansH Ericsson, B Hamrén, S Bergstrand, et al.
European Journal of Biochemistry|January 2, 1978
Purified human somatomedin A and rat multiplication stimulating activity. Mitogens for cultured fibroblasts that cross-react with the same growth peptide receptorsM M Rechler, L Fryklund, S Nissley, et al.
Endocrine|December 15, 2010
Effects of constant infusion with insulin-like growth factor-I (IGF-I) to immature female rats on body weight gain, tissue growth, and sexual function : Evidence that such treatment does not affect sexual maturation or fertilityN M Gruaz, V d'Allèves, Y Charnay, et al.
Endocrine|February 1, 1997
Effects of constant infusion with insulin-like growth factor-I (IGF-I) to immature female rats on body weight gain, tissue growth and sexual function. Evidence that such treatment does not affect sexual maturation of fertilityN M Gruaz, V d'Allèves, Y Charnay, et al.
The Journal of Biological Chemistry|July 5, 1989
Isolation and characterization of a glycosylated form of human insulin-like growth factor I produced in Saccharomyces cerevisiaeP Gellerfors, K Axelsson, A Helander, et al.
Clinical Endocrinology|June 1, 1977
Increasing growth with raised circulating somatomedin but normal immunoassayable growth hormoneR Hoffenberg, A Howell, S Epstein, et al.
Clinical Endocrinology|August 31, 2002
The metabolic effects of short-term administration of physiological versus high doses of GH therapy in GH deficient adultsK Yuen, D Cook, K Ong, et al.
Acta Physiologica Scandinavica|February 1, 1986
Localization of IGF-I in adult rats. Immunohistochemical studiesI Andersson, H Billig, L Fryklund, et al.
Biochimica Et Biophysica Acta|September 11, 1987
Biological characterization of purified native 20-kDa human growth hormoneJ L Kostyo, A Skottner, P Brostedt, et al.
The Journal of Clinical Endocrinology and Metabolism|June 29, 2006
The d3/fl-growth hormone (GH) receptor polymorphism does not influence the effect of GH treatment (66 microg/kg per day) or the spontaneous growth in short non-GH-deficient small-for-gestational-age children: results from a two-year controlled prospective study in 170 Spanish patientsA Carrascosa, C Esteban, R Espadero, et al.
Pageof 6